On April 24, the Centers for Medicare and Medicaid Services announced plans to overhaul the Meaningful Use program by turning to a focus on interoperability. Thus, it only makes sense that the agency ...

Health informatics leaders at NYU Langone Health think fully autonomous clinical AI is coming in the next five years or so, ...

On Wednesday, the Centers for Medicare & Medicaid Services launched a new initiative in tandem with the White House and HHS aimed at creating a more patient-centric healthcare ecosystem. As part of ...

Otsuka Pharmaceutical is broadening its scope in rare disease, striking a deal to acquire Jnana Therapeutics and its lead drug candidate, a small molecule on track for pivotal testing in a metabolic ...

A Boehringer Ingelheim drug now has FDA approval as an earlier treatment for lung cancers expressing a certain genetic signature, a regulatory decision handed out under the agency’s new pilot program ...

The millions of people who regularly suffer from heartburn now have a new FDA-approved treatment option, a Phathom Pharmaceuticals drug with a different mechanism of action than older medications that ...

NationsBenefits, a fintech, benefits and outcomes platform, has acquired food-as-medicine company Good Measures, the companies announced Tuesday. Plantation, Florida-based NationsBenefits is a ...

Galapagos believed so strongly in its work developing new cancer cell therapies that it pinned its future on them. This past winter, the Belgian drugmaker unveiled a plan to spin out the rest of the ...

More than 400 rural hospitals across the country are at risk of closure, battling a mix of reimbursement issues, workforce struggles and policy decisions that have left safety net providers ...

Positive Development, a developmental therapy provider for children with autism, announced Wednesday that it raised $51.5 million in Series C funding. The McLean, Virginia-based company’s model is ...

Johnson & Johnson is boosting its immunology and inflammation drug pipeline with the acquisition of Proteologix, a startup whose most advanced program is ready for Phase 1 testing in asthma and atopic ...

Healthcare leaders must resist using AI as a substitute for staffing. Instead, invest in workforce optimization technology that empowers nurses, creates flexible pathways, and addresses the systemic ...